Due to its ability to promote the aggregation of misfolded Aβ peptide, they postulated that A2M, an acute phase protein and chaperone protein, may be involved in the inflammation and pathogenesis of preclinical AD [74,75]. Here, A2M is linked to Alzheimer disease.